TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive Orlando Hospital Severs MD Anderson Ties, Forming Center with University of Florida January 10, 2014
TCL Archive Center Leaders Ok Consortium Center Guidelines, Go Along With Most Core Grant Changes Backed By NCI April 19, 1985
